Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
- CAD | -.--% | -5.08% | +3.70% |
2020 | Transcript : Correvio Pharma Corp. - Shareholder/Analyst Call | |
2019 | Transcript : Correvio Pharma Corp., Q3 2019 Earnings Call, Nov 14, 2019 |
Umsatz 2018 | 28.67 Mio. 39.49 Mio. 26.07 Mio. | Umsatz 2019 | 32.63 Mio. 44.94 Mio. 29.67 Mio. | Marktwert | 27.28 Mio. 37.57 Mio. 24.8 Mio. |
---|---|---|---|---|---|
Nettoergebnis 2018 | -16 Mio. -22.04 Mio. -14.55 Mio. | Nettoergebnis 2019 | -35 Mio. -48.2 Mio. -31.82 Mio. | EV / Sales 2018 | 5.13 x |
Nettoschuld 2018 | 25.92 Mio. 35.7 Mio. 23.57 Mio. | Nettoschuld 2019 | 33.9 Mio. 46.69 Mio. 30.83 Mio. | EV / Sales 2019 | 1.87 x |
KGV 2018 |
-7.1
x | KGV 2019 |
-0.68
x | Beschäftigte | - |
Rendite 2018 * |
-
| Rendite 2019 |
-
| Streubesitz | 86.23% |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Ram Ramkumar
BRD | Director/Board Member | - | - |
Andreas Stickler
BRD | Director/Board Member | 53 | - |
Robert Ford
BRD | Director/Board Member | - | - |
% 1. Jan. | Kap. | |
---|---|---|
+3.70% | 27.65 Mio. | |
+10.08% | 9.12 Mrd. | |
-15.94% | 4.8 Mrd. | |
+18.47% | 3.72 Mrd. | |
+1.89% | 3.8 Mrd. | |
+25.82% | 2.58 Mrd. | |
-24.63% | 2.36 Mrd. | |
-29.37% | 2.11 Mrd. | |
+2.55% | 1.86 Mrd. | |
-0.50% | 1.64 Mrd. |